JP Morgan Chase
IDIX

JP Morgan Chase’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

JP Morgan Chase’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,134,747
Closed -$27.3M – 4382
2014
Q2 		$27.3M Buy
1,134,747
+1,103,231
+3,501% +$11.5M 0.01% 1155
2014
Q1 		$190K Sell
31,516
-34,066
-52% -$238K ﹤0.01% 3419
2013
Q4 		$393K Sell
65,582
-37,237
-36% -$172K ﹤0.01% 3583
2013
Q3 		$533K Sell
102,819
-41,640
-29% -$182K ﹤0.01% 3605
2013
Q2 		$522K Buy
+144,459
New +$591K ﹤0.01% 3590

JP Morgan Chase's IDIX Position: Q3 2014 in Review

JP Morgan Chase sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 1,134,747 shares — an estimated $27.3M sold.

JP Morgan Chase first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $27.3M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • JP Morgan Chase reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • JP Morgan Chase sold 1,134,747 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $27.3M.
  • JP Morgan Chase first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • JP Morgan Chase's IDENIX PHARMACEUTICALS INC position peaked at $27.3M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on JP Morgan Chase's 13F filing for Q3 2014, filed 14 Nov 2014.